title: CANCER. The odds of immunotherapy success.
authors.affiliation: Department of Pathology and Immunology, Washington University, St. Louis, MO, USA. mgubin@path.wustl.edu.
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Gubin
authors.affiliation: Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Schreiber
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D000951:Antigens, Neoplasm / Q000235:genetics*; D054316:Biomarkers, Pharmacological; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D054316:Biomarkers, Pharmacological; D060908:CTLA-4 Antigen